Form 4: Elanco Director Receives Annual Equity Award

Elanco Animal Health Director Art A. Garcia was granted 10,314 deferred stock units as part of his annual equity award.

Summary

• Art A. Garcia, a non-employee Director of Elanco Animal Health Inc. (ELAN), received an annual equity award.
• The award consisted of 10,314 deferred stock units of common stock.
• The transaction occurred on November 28, 2025, with a price of $0 per unit, indicating a grant rather than a purchase.
• Following this transaction, Garcia beneficially owns 91,278 shares of common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 7

Explanation: The filing reports a routine annual equity award to a non-employee director, which is a standard corporate governance practice to align director interests with shareholders, indicating a neutral to slightly positive sentiment.

Positives

• The grant of 10,314 deferred stock units to a non-employee director aligns management and shareholder interests by increasing the director's equity stake in the company.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Grant of 10,314 deferred stock units to Art A. Garcia, a non-employee director, as part of his annual equity award, which is a standard related party transaction for director compensation.

Stakeholder Impact

• Shareholders: The grant of equity to a director helps align the director's financial interests with those of the shareholders, potentially fostering better long-term decision-making.

Key Dates

Recommendation

This Form 4 filing reports a routine annual equity award to a non-employee director, which is a standard compensation practice and does not provide new information that would alter the fundamental investment thesis for Elanco Animal Health Inc. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Elanco, ELAN, Form 4, Insider Transaction, Director Compensation, Equity Award, Deferred Stock Units, Corporate Governance